Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL2487509 | 1.00 | CA1 (0.71) | — | |
| Bicarbonate SCHEMBL150637 | 1.00 | — | — | |
| Bicarbonate SCHEMBL28576574 | 1.00 | — | — | |
| Bicarbonate SCHEMBL1401746 | 1.00 | CA1 (0.71) | — | |
| Bicarbonate SCHEMBL150901 | 1.00 | — | — | |
| Bicarbonate SCHEMBL22476040 | 1.00 | CA1 (0.71) | — | |
| Bicarbonate SCHEMBL1358630 | 1.00 | CA1 (0.71) | — | |
| Bicarbonate SCHEMBL153475 | 1.00 | CA1 (0.71) | — | |
| Bicarbonate SCHEMBL14563498 | 0.94 | — | — | |
| Bicarbonate SCHEMBL537207 | 0.93 | CA1 (0.83) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 459 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600633-B2 | Nanostructured carbons and methods of preparing the same | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-04-14 | — | — | US | claimed |
| EP-4633381-A1 | COMPOSTIONS FOR USE IN THE PROPHYLACTIC TREATMENT OF HYPOCALCEMIA IN A RUMINANT ANIMAL | Vilofoss A/S (DK) | 2025-10-22 | — | — | EP | claimed |
| CN-119709198-A | Eu3+/Mn4+Co-doped luminescent material, and preparation method and application thereof | 安徽三联学院 | 2025-03-28 | — | — | CN | claimed |
| CN-119666896-A | Quantitative determination method for two impurities of basic lanthanum carbonate in raw material drug lanthanum carbonate octahydrate | 上海明捷医药科技有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119120018-A | Mn (Mn)4+Doped deep red light luminescent material, and preparation method and application thereof | 安徽三联学院 | 2024-12-13 | — | — | CN | claimed |
| US-12145131-B2 | Polymeric lanthanum nanocomposite, and preparation method and application thereof | NANJING UNIVERSITY (CN) | 2024-11-19 | — | — | US | claimed |
| CN-118619327-A | Lanthanum carbonate hydroxide, preparation method thereof, lanthanum oxide and catalyst | 武汉大学 | 2024-09-10 | — | — | CN | claimed |
| WO-2024125758-A1 | COMPOSTIONS FOR USE IN THE PROPHYLACTIC TREATMENT OF HYPOCALCEMIA IN A RUMINANT ANIMAL | VILOFOSS A/S (DK) | 2024-06-20 | — | — | WO | claimed |
| CN-117947461-A | Preparation method, structure and application of non-noble metal oxide modified ultra-fine noble metal nano particles synthesized by low-temperature heat treatment | 大连理工大学 | 2024-04-30 | — | — | CN | claimed |
| CN-116443913-B | Controllable preparation method of superfine lanthanum oxide | 江苏国盛新材料有限公司 | 2023-12-08 | — | — | CN | claimed |
| EP-1294384-B1 | USE OF LANTHANUM COMPOUNDS FOR THE TREATMENT OF BONE DISEASES | SHIRE HOLDINGS AG (CH) | 2009-03-11 | — | — | EP | claimed |
| EP-1947960-A2 | HYPERPHOSPHATEMIA IN DOMESTIC ANIMALS: COMPOSITIONS AND METHODS OF TREATMENT | Altairnano, Inc (US) | 2008-07-30 | — | — | EP | claimed |
| US-20080069860-A1 | Administering a rare earth compound with calcium and aluminum salt or hydrophilic exchange resin in foods | SPECTRUM PHARMACEUTICALS, INC. | 2008-03-20 | — | — | US | claimed |
| WO-2007056721-A2 | TREATMENT OF CHRONIC KIDNEY DISEASE (CKD) SUBJECTS USING LANTHANUM COMPOUNDS | SHIRE INTERNATIONAL LICENSING B.V (NL) | 2007-05-18 | — | — | WO | claimed |
| EP-1785142-A1 | Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds | Shire International Licensing B.V. (NL) | 2007-05-16 | — | — | EP | claimed |
| US-20070104799-A1 | Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds | SHIRE INTERNATIONAL LICENSING B.V. (NL) | 2007-05-10 | — | — | US | claimed |
| US-7192609-B2 | Use of rare earth compounds for the prevention of kidney stone disease | SHIRE INTERNATIONAL LICENSING B.V. (NL) | 2007-03-20 | — | — | US | claimed |
| US-20070048390-A1 | Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases | SHIRE INTERNATIONAL LICENSING B.V. (NL) | 2007-03-01 | — | — | US | claimed |
| WO-2007022466-A2 | HYPERPHOSPHATEMIA IN DOMESTIC ANIMALS: COMPOSITIONS AND METHODS OF TREATMENT | ALTAIRNANO, INC. (US) | 2007-02-22 | — | — | WO | claimed |
| US-7078059-B2 | Treatment of bone diseases | SHIRE HOLDINGS AG (CH) | 2006-07-18 | — | — | US | claimed |